Legal Representation
Attorney
Andrew J. Gray IV
USPTO Deadlines
Next Deadline
1354 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-18)
Due Date
April 18, 2029
Grace Period Ends
October 18, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 18, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 18, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 14, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 13, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 14, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 14, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 14, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 30, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 30, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 30, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 4, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 4, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 4, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 1, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 1, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 1, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 4, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 28, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 2, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 27, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Scientific apparatus, namely, microfluidic technology-based chips which enable investigators to perform co-cultures of multiple cell types in 3-D with high-throughput screening capabilities for biomedical research and drug discovery and a variety of patient-derived in vitro organ-on-a-chip models which closely recapitulate the pathophysiology of diseases, thus can be efficiently applicable to target identification and compound screening, patient stratification, and biomarker identification, especially in the areas of fibrosis, oncology, and ophthalmology
First Use Anywhere:
20220900
First Use in Commerce:
20220900
Class 042
Scientific research services, namely, the development of novel platforms and high-throughput disease models for precision medicine in the area of high unmet medical needs, developing novel drugs and is engaged in drug repositioning for the treatment of intractable diseases for assay development, safety evaluation, and drug discovery
First Use Anywhere:
20220900
First Use in Commerce:
20220900
Additional Information
Pseudo Mark
CURATOR
Classification
International Classes
009
042